5.47
Generation Bio Co stock is traded at $5.47, with a volume of 100.49K.
It is up +7.05% in the last 24 hours and down -10.47% over the past month.
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
See More
Previous Close:
$5.11
Open:
$5.16
24h Volume:
100.49K
Relative Volume:
0.37
Market Cap:
$36.84M
Revenue:
$21.23M
Net Income/Loss:
$-72.42M
P/E Ratio:
-0.8076
EPS:
-6.7728
Net Cash Flow:
$-81.69M
1W Performance:
+3.80%
1M Performance:
-10.47%
6M Performance:
+51.94%
1Y Performance:
-75.80%
Generation Bio Co Stock (GBIO) Company Profile
Name
Generation Bio Co
Sector
Industry
Phone
857-529-5908
Address
301 BINNEY STREET, CAMBRIDGE
Compare GBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
GBIO
Generation Bio Co
|
5.47 | 34.43M | 21.23M | -72.42M | -81.69M | -6.7728 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.20 | 103.89B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
654.74 | 69.11B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.70 | 58.49B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
869.83 | 52.62B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
191.92 | 40.46B | 447.02M | -1.18B | -906.14M | -6.1812 |
Generation Bio Co Stock (GBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-25 | Downgrade | Wedbush | Outperform → Neutral |
| Oct-19-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Nov-08-22 | Initiated | Canaccord Genuity | Buy |
| Dec-14-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-08-21 | Initiated | JMP Securities | Mkt Outperform |
| Feb-24-21 | Initiated | William Blair | Outperform |
| Feb-18-21 | Initiated | Needham | Buy |
| Jul-07-20 | Initiated | Cowen | Outperform |
| Jul-07-20 | Initiated | JP Morgan | Overweight |
| Jul-07-20 | Initiated | Jefferies | Buy |
| Jul-07-20 | Initiated | Wedbush | Outperform |
View All
Generation Bio Co Stock (GBIO) Latest News
Is Generation Bio Co. stock poised for growthMarket Sentiment Report & Real-Time Volume Analysis - newser.com
How Generation Bio Co. stock reacts to inflationary pressures2025 Market Outlook & Fast Entry and Exit Trade Plans - newser.com
Ranking Generation Bio Co. among high performing stocks via toolsPortfolio Update Report & Real-Time Chart Pattern Alerts - newser.com
What’s next for Generation Bio Co. stock priceTrade Exit Summary & Technical Confirmation Trade Alerts - newser.com
Using data models to predict Generation Bio Co. stock movementQuarterly Profit Report & Comprehensive Market Scan Insights - newser.com
Is Generation Bio Co. stock reversal real or fakeJuly 2025 Levels & Stepwise Entry and Exit Trade Signals - newser.com
Heatmap analysis for Generation Bio Co. and competitorsIndex Update & Safe Swing Trade Setup Alerts - newser.com
Will Generation Bio Co. stock go up soon2025 Trade Ideas & Smart Swing Trading Techniques - newser.com
Why Generation Bio Co. stock could see breakout soonWeekly Investment Recap & Entry Point Confirmation Signals - newser.com
Generation Bio earnings missed by $0.54, revenue fell short of estimates - Investing.com Philippines
Is this a good reentry point in Generation Bio Co.July 2025 Sector Moves & Daily Entry Point Trade Alerts - newser.com
Will Generation Bio Co. stock pay special dividendsWeekly Trade Recap & Consistent Income Trade Recommendations - newser.com
Why analysts upgrade Generation Bio Co. stockJuly 2025 Selloffs & Accurate Technical Buy Alerts - newser.com
Will Generation Bio Co. stock recover faster than marketWeekly Earnings Recap & Real-Time Buy Signal Notifications - Fundação Cultural do Pará
Generation Bio Co. Reports Strategic Restructuring and Financial Highlights - TipRanks
Generation Bio Narrows Loss And Gets Wall Street’s Vote Of Confidence - Finimize
Generation Bio Co reports results for the quarter ended September 30Earnings Summary - TradingView
Generation Bio's Q3 net loss narrows to $5.5 mln - MarketScreener
Generation Bio Announces Third Quarter 2025 Financial Results - The Manila Times
Generation Bio Co Stock Analysis and ForecastSector Performance Drivers & Rapid Capital Trading Plans - earlytimes.in
How Generation Bio Co. stock performs in high volatility markets2025 Price Momentum & Smart Investment Allocation Tips - newser.com
What the charts say about Generation Bio Co. todayJuly 2025 Reactions & Community Supported Trade Ideas - newser.com
Generation Bio Co Stock (GBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Generation Bio Co Stock (GBIO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Quinn Anthony G. | Director |
Jan 13 '25 |
Buy |
0.97 |
85,000 |
82,450 |
299,286 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):